Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2011/0300233 CONDITIONING COMPOSITION
The present invention is directed to a composition for the conditioning of a dental mineralized surface and/or a dental implant and/or for increasing the...
2011/0300232 EFFECTS OF NITRIC OXIDE (NO) AND iNOS ON EXPRESSION AND SIGNAL TRANSDUCTION IN CANCER AND ITS USE IN DRUG...
Nitric Oxide (NO) acts as double-edged sword, which induces and prevents cell death, depending on various factors. The mechanism for the NO regulation of cells...
2011/0300231 Fluid purification system
Certain disclosed embodiments concern systems and methods of preparing dialysate for use in a home dialysis system that is compact and light-weight relative to...
2011/0300230 FLUID PURIFICATION SYSTEM
Disclosed are systems and methods of preparing dialysate for use in a home dialysis system that is compact and light-weight relative to existing systems and...
2011/0300229 TREATING OR PREVENTING ROTAVIRUS INFECTION
Use of one or more of conjugated linoleic acid (CLA), high CLA milk fat, or one or more bovine milk lipid compositions to treat or prevent rotavirus infection.
2011/0300228 COMPOSITION, WITH/WITHOUT AT LEAST ONE EASILY OXIDISED COMPONENT, COMPRISING AN EDIBLE PROCESSED OIL OR FAT...
The present invention relates to a composition for reducing the tendency of an animal to enter sexual maturation, reducing or preventing oxidative damage in an...
2011/0300227 MALIGNANT NEOPLASM TREATMENT PROTOCOL
Methods, compositions, and strategies for the treatment of malignant neoplasms are presented herein. The treatment modalities are directed towards exploiting...
2011/0300226 PEPTIDE PARTICLE FORMULATION
A composition as disclosed is comprised of a plurality of groups of particles. The particles are comprised of a biocompatible polymer which maybe a co-polymer...
2011/0300225 NUTRITIONAL COMPOSITIONS WITH COATED LIPID GLOBULES
The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a lipid globules coated with...
2011/0300224 TASTE MASKED DOSAGE FORM OF PHARMACEUTICALLY ACCEPTABLE SALT OF ESCITALOPRAM
A taste masked dosage form of pharmaceutical acceptable salt of escitalopram comprising (a) resin complex of pharmaceutical acceptable salt of escitalopram and...
2011/0300223 IMMUNOGENIC COMPOSITION
An immunogenic composition includes as an effective ingredient an antigen-adjuvant microparticle complex containing an antigen encapsulated in an adjuvant...
2011/0300222 LUMINESCENT POROUS SILICON NANOPARTICLES, METHODS OF MAKING AND USING SAME
The disclosure relates to imaging agents and drug delivery systems.
2011/0300221 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
Methods are provided for inhibiting stenosis following vascular trauma or disease in a mammalian host, comprising administering to the host a therapeutically...
2011/0300220 SOLID CALCIUM LACTATE IN SUBSTANTIALLY SPHERICAL FORM
Solid calcium lactate in the form of substantially spherical particles, characterised in that the spherical particles have a particle size distribution such...
2011/0300219 NANOSTRUCTURES FOR DRUG DELIVERY
The present invention provides compositions, preparations, formulations, kits, and methods useful for treating subjects having cancer or at risk of developing...
2011/0300218 NOVEL SOLID STATE FORMS OF RANOLAZINE SALTS
Provided herein are solid state forms of ranolazine salts. Also provided is a stable amorphous form of ranolazine hydrochloride having a water content of less...
2011/0300217 HYDROMORPHONE THERAPY
A hydromorphone composition, a hydromorphone dosage form and a method for administering hydromorphone are disclosed, indicated for the management of pain.
2011/0300216 Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
A tablet comprising: (a) an active ingredient; and (b) at least one member of an effervescent couple, wherein said tablet dissolves in water in not more than...
2011/0300215 TABLET FORMULATION OF EZATIOSTAT
Disclosed herein are tablets comprising ezatiostat hydrochloride wherein the ezatiostat hydrochloride comprises from about 75 to about 82 percent by weight of...
2011/0300214 PHARMACEUTICAL COMPOSITIONS COMPRISING 5-CHLORO-N-(-METHYL)-2-THIOPHENCARBOXAMID
The invention relates to pharmaceutical compositions comprising 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin- ...
2011/0300213 Oral formulations of bipolar trans carotenoids
The subject invention relates to a variety of formulations of bipolar trans carotenoids including pharmaceutical compositions for oral delivery of a bipolar...
2011/0300212 Pharmaceutical Formulation
The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component...
2011/0300211 SOFT-GELATIN CAPSULE FORMULATION
The present invention provides a soft gelatin capsule formulation of a 15-keto-prostaglandin compound, which includes: a soft gelatin capsule shell including...
2011/0300210 CONTROLLED RELEASE NANOPARTICULATE CLOZAPINE COMPOSITIONS
Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which...
2011/0300209 MODIFIED RELEASE SOLID PHARMACEUTICAL COMPOSITIONS OF TRIMETAZIDINE AND PROCESS THEREOF
There is provided a modified release solid pharmaceutical composition comprising Trimetazidine and polyethylene oxide, wherein the composition does not include...
2011/0300208 SEGMENTED PHARMACEUTICAL DOSAGE FORMS
A pharmaceutical tablet adapted for accurate division of a dose of a drug into two or more smaller doses, which tablet has two or more segments.
2011/0300207 METHOD OF TREATING POST-SURGICAL ACUTE PAIN
A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium...
2011/0300206 VACCINES AGAINST CHLAMYDIAL INFECTION
The present invention relates to compositions comprising proteins or polynucleotides of Chlamydia sp., in particular combinations of proteins or polynucleotides...
2011/0300205 SELF REPLICATING RNA MOLECULES AND USES THEREOF
This application discloses self-replicating RNA molecules that contain modified nucleotides, compositions that contain the self-replicating RNA molecules, and...
2011/0300204 NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE
The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a large lipid globule size, having...
2011/0300203 CARTILAGE REGENERATION WITHOUT CELL TRANSPLANTATION
Provided is a method of causing a cell to migrate to a scaffold. Also provided is a method of treating a mammal that has a cartilage defect. Further provided is...
2011/0300202 Medical item for long term durg release
Polymeric articles capable of releasing drugs at therapeutic levels over extended periods of time, and methods for producing the extended release articles.
2011/0300201 DELIVERY SYSTEM FOR CO-FORMULATED ENZYME AND SUBSTRATE
The invention provides methods, compositions, systems, and kits that include an enzyme/substrate co-delivery system. The liquid delivery system includes at...
2011/0300200 Effect Pigment And The Use Thereof In Cosmetics And In The Foods And Pharmaceuticals Sector
The present invention relates to intensely coloured and light-stable effect pigments based on transparent, undoped SiO.sub.2 flakes, which are distinguished by...
2011/0300199 PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR SCALP AND THEIR USE IN COSMETIC...
Peptides of general formula (I): R.sub.1-W.sub.p-X.sub.n-AA1-AA.sub.2-AA.sub.3-AA.sub.4-Y.sub.m-R.sub.2 their stereoisomers, mixtures thereof, and/or their...
2011/0300198 HYDROCOLLOID - ESSENTIAL OIL PATCHES
The present invention relates to dermal patches comprising natural polysaccharides without the need for any pressure sensitive synthetic polymers. Particularly,...
2011/0300197 FOOD PRODUCT
The present invention relates to a food product comprising an outer portion and an inner portion, wherein the inner portion comprises myrtle and has a moisture...
2011/0300196 Method And System For Automatic Or Manual Evaluation To Provide Targeted And Individualized Delivery Of...
A system and method are provided for targeted and individualized delivery of multiple skin benefit agents to the skin of a user. The image of a predetermined...
2011/0300195 Ophthalmic Compositions Comprising Calcineurin Inhibitors or mTOR Inhibitors
The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for...
2011/0300194 Flexible Bone Composite
The present invention relates in general to implantable flexible bone composites, and method for preparing the same. The flexible bone composite includes at...
2011/0300193 AMBIENT STORED BLOOD PLASMA EXPANDERS
A liquid plasma expander or resuscitation fluid composition for use in a subject in need thereof, comprising, consisting of, or consisting essentially of: (a) a...
2011/0300192 MAGNESIUM OXIDE GRANULES
Magnesium oxide granules which are excellent in dissolution property, are palatable, rarely leave any rough feeling in the oral cavity and have a good color in...
2011/0300191 MULTIPLE-LAYER IMMUNE BARRIER FOR DONOR CELLS
A system is provided, including a plurality of donor cells and a first alginate structure that encapsulates the plurality of donor cells. The first alginate...
2011/0300190 COMPOUND, COMPOSITION AND USES THEREOF
The disclosure herein provides a compound of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof. The steps...
2011/0300189 ANTIMICROBIAL COLLOIDAL SILVER PRODUCTS AND METHOD OF MAKING SAME
Gelatinous materials combined with the Colloidal Silver additive to formulate an antimicrobial product having cushioning properties. Embodiments of the present...
2011/0300188 Glassy calcium phosphate particulates, coatings and related bone graft materials
Calcium phosphate and related coating powder particles comprising a surface component comprising a silicate content, plasma sprayed coatings thereof on...
2011/0300187 ANTIOXIDANT CAMPTOTHECIN DERIVATIVES AND ANTIOXIDANT ANTINEOPLASTIC NANOSPHERES THEREOF
The present invention is directed to antioxidant derivatives of camptothecin and antioxidant derivatives of camptothecin analogs and the preparation of...
2011/0300186 Functionalized Nano- and Micro-materials for Medical Therapies
Compositions containing an optionally surface-functionalized mesoporous support and a biologically active agent, and pharmaceutical compositions of the same,...
2011/0300185 IMMUNOGENIC ESCHERICHIA COLI HEAT STABLE ENTEROTOXIN
The present invention relates to methods and compositions for the treatment and prevention of diarrhea and diarrheal related diseases and disorders in both...
2011/0300184 PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING BONE CONDITIONS
Provided herein is a pharmaceutical composition for treating, preventing or ameliorating a bone or cartilage condition and methods of making and using the same.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.